Dutch study tracks COVID antivirals in High-Risk patients
NCT ID NCT05195060
First seen Jan 11, 2026 · Last updated Jun 17, 2026 · Updated 25 times
Summary
This study followed over 1,100 high-risk COVID-19 patients in the Netherlands who received new antiviral drugs or monoclonal antibodies. Researchers collected blood samples and nasal swabs over 90 days to see how the virus and the body's immune response changed during treatment. The goal was to learn which patients benefit most and to watch for new virus variants, not to test a new treatment directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Amsterdam University Medical Centre
Amsterdam, North Holland, 1105 AZ, Netherlands
-
Amsterdam University Medical centre - VUMC
Amsterdam, North Holland, 1081 HV, Netherlands
-
Leiden universitair medisch centrum
Leiden, 2333ZA, Netherlands
-
Radboud Universitair Medisch Centrum
Nijmegen, 6525GA, Netherlands
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.